Skip to main navigation

Overview
Corporate
News & Events
Stock Information
Financial Information
- SEC Filings
- Quarterly Results
IR Resources

News & Events

News Releases

News Releases

All
2023
2022
2021
2020
2019

2021.07.07

Adagene Announces Authorization of Share Repurchase Program up to US$20 Million

2021.06.16

Adagene Announces Inclusion in FTSE Russell Indexes

2021.05.25

Adagene to Present at Upcoming Investor Conferences

2021.05.19

Adagene Presents Clinical Data from NEObody™ Program, ADG106, Anti-CD137 Agonist, in an Abstract at ASCO 2021 Annual Meeting

2021.04.13

Adagene Presents Preclinical Data from Lead SAFEbody™ Program, ADG126, at the American Association for Cancer Research (AACR) Annual Meeting 2021

Pagination

First page
Previous page
…
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Page 11
Page 12
Next page
Last page

Displaying 36 - 40 of 56

Shareholder Tools

© 2023 Adagene Inc.

Footer Bottom

Home
Privacy
Terms of Use
Contact
Site Credits
LinkedIn